Fingerprint
Dive into the research topics of 'Phase II study of nilotinib in melanoma harboring KIT alterations following progression to prior KIT inhibition'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of nilotinib in melanoma harboring KIT alterations following progression to prior KIT inhibition
Richard D. Carvajal, Donald P. Lawrence, Jeffrey S. Weber, Thomas F. Gajewski, Rene Gonzalez, Jose Lutzky, Steven J. O'Day, Omid Hamid, Jedd D. Wolchok, Paul B. Chapman, Ryan J. Sullivan, Jerrold B. Teitcher, Nikhil Ramaiya, Anita Giobbie-Hurder, Cristina R. Antonescu, Michael C. Heinrich, Boris C. Bastian, Christopher L. Corless, Jonathan A. Fletcher, F. Stephen Hodi
Research output: Contribution to journal › Article › peer-review
108
Scopus
citations